Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-28
2009-11-03
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S320000, C514S415000, C514S416000, C544S143000, C546S196000, C546S197000, C546S258000, C548S469000, C548S483000, C548S484000, C548S486000, C548S491000
Reexamination Certificate
active
07612065
ABSTRACT:
The present invention relates to inhibitors of JNK, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
REFERENCES:
patent: 5849710 (1998-12-01), Battistini et al.
patent: 0685463 (1995-12-01), None
patent: 94/18194 (1994-08-01), None
patent: 96/16046 (1996-05-01), None
patent: 99/01449 (1999-01-01), None
patent: 99/51590 (1999-10-01), None
patent: 99/65875 (1999-12-01), None
Bozyczko-Coyne D et al. “Targeting the JNK pathway for therapeutic benefit in CNS disease”, Curr Drug Target CNS Neurol Disord. Feb. 2002; 1 (1): 31-49.
Tran, Viet Hung; Nguyen, Quang Dat; Pham, Minh Thuy, Tap Chi Duoc Hoc (12), 10-12 (Vietnamese) 2000, cited in Chemical Abstracts 2001: 349350.
Tran, Viet Hung; Nguyen, Quang Dat; Pham, Minh Thuy, Tap Chi Duoc Hoc (5), 14-16 (Vietnamese) 2000, cited in Chemical Abstracts 2000: 692850.
Zhavrid, S.V., et al., “Synthesis of Indole Derivatives and Their Antimicrobial Activitiy”, Chemical Abstract, 99(9), Aug. 29, 1983, Columbus, OH, Abstract No. 70513n.
Khim. -Farm. ZH., vol. 17, No. 2, (1983) pp. 153-158, anmd Database Chemical Abstracts ‘Online’ CA 99:70513.
Abramenko, P.I., et al. “Synthesis of Substituted Indolothiazoles and Thienothiazoles”, Chemical Abstract, vol. 90, No. 19, May 7, 1979, Columbus, OH, abstract No. 152060r.
Zh. Vses. Khim. O.V.A., vol. 23, No. 6 (1978), pp. 711-712, and Database Chemical Abstracts ‘Online’ CA 90:152060.
Santilli, A.A., et al., “7-Deazapurines VI. Syntheses and reactions of 5, 7-dihydro-4-methyl-2-phenyl-7-substitute d-6H-pyrrolo (2,3-d) pyrimidin-6-ones”, J. Heterocyclic Chem., 13:135-137 (1976).
Plana, F., et al., “N-Ethanol-beta-isatoxime”, Chemical Abstract, 80(6) (1974).
Plana, F., et al., Chemical Abstract, Cryst. Struct. Commun., 2(4): 613-617, (1973).
Miravitlles, C., et al., “Determination of hydrogen bonds in organic compounds by x-ray diffraction”, 82(23), Chemical Abstract, (1975).
Miravitlles, C., et al., Chemical Abstract, Circ. Farm., 32(245): 613-622, Database Chemical Abstracts (1974).
Hirose, N, et al., “Benzoheterocyclic derivatives. Xl. Synthesis and pharmacological actions of indoline derivatives”, 76 (9), Chemical Abstract, (1972).
Zasshi, Y., Chemical Abstract, 91(12):1323-1334, Database Chemical Abstracts (1971).
Izquierdo, A., et al., “Analytical applications of N-substituted beta-isatin oximes”, Chemical Abstracts (1971).
Izquierdo, A., et al., Abstract. Inform Quim. Anal., 23(6): 161-168(1969).
Ludvik, D., Analytically important reactions of isatin oximes:, Chemical Abstracts, 73(2) (1970).
Ludvik, D., Abstract, Sb. Vys. Sk. Chem.-Technol. Praz, Anal. Chem. 3:85-112 (1968).
Homes et al., Gastroenterology Jan. 2002, 122 (1) pp. 7-14.
Bemis Guy
Cao Jingrong
Gao Huai
Green Jeremy
Harrington Edmund
Che Jennifer G.
Sackey Ebenezer
Vertex Pharmaceuticals Incorporated
Wilson James O
LandOfFree
Inhibitors of c-JUN N-terminal kinases (JNK) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of c-JUN N-terminal kinases (JNK), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of c-JUN N-terminal kinases (JNK) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112248